Sanofi Contingent Value Rights
GCVRZ
GCVRZ was delisted on the 3rd of March, 2020.
114 hedge funds and large institutions have $12.6M invested in Sanofi Contingent Value Rights in 2015 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 17 increasing their positions, 23 reducing their positions, and 16 closing their positions.
64% more capital inflows, than outflows
Capital inflows: $3.27M | Capital outflows: $1.99M
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
3% less funds holding
Funds holding: 117 → 114 (-3)
26% less repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 23
44% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 16
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Stonehill Capital Management
New York
|
+$1.97M |
| 2 |
NGA
New Generation Advisors
Manchester,
Massachusetts
|
+$861K |
| 3 |
TL
TowerView LLC
New York
|
+$99.1K |
| 4 |
Elliott Management
New York
|
+$93.7K |
| 5 |
Millennium Management
New York
|
+$70.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Whitebox Advisors
Minneapolis,
Minnesota
|
-$714K |
| 2 |
Commonwealth of Pennsylvania Public School Employees Retirement System
Harrisburg,
Pennsylvania
|
-$604K |
| 3 |
Brown Advisory
Baltimore,
Maryland
|
-$271K |
| 4 |
Deltec Asset Management
New York
|
-$138K |
| 5 |
CL
CSS LLC
Chicago,
Illinois
|
-$90.5K |
GCVRZ Hedge Fund Activity: Q4 2015 in Review
114 of the 3,823 institutional investors tracked by Wall St. Rank reported a position in Sanofi Contingent Value Rights (GCVRZ) for Q4 2015, worth a combined $12.6M — down 35% from $19.4M a quarter earlier.
Sellers outnumbered buyers: 16 funds closed out of GCVRZ and 9 opened new positions — a net loss of 7 holders — while 23 trimmed existing stakes and 17 added.
The largest buyer was Stonehill Capital Management, adding an estimated $1.97M. The largest seller was Whitebox Advisors, cutting an estimated $714K.
- 114 institutional investors held Sanofi Contingent Value Rights (GCVRZ) as of Q4 2015, down from 117 in Q3 2015.
- Funds reported $12.6M of Sanofi Contingent Value Rights stock for Q4 2015, down 35% quarter-over-quarter.
- 9 funds opened new Sanofi Contingent Value Rights positions in Q4 2015 and 16 closed out, a net change of -7 holders.
- The largest Sanofi Contingent Value Rights buyer in Q4 2015 was Stonehill Capital Management, an estimated $1.97M added.
- The largest Sanofi Contingent Value Rights seller in Q4 2015 was Whitebox Advisors, an estimated $714K sold.
Based on aggregated 13F filings for Q4 2015.